Evidence map›Paper›PMID 22232280›Full record

ArticleAntimicrobial agents and chemotherapy2012

Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.

Eric Legrand, Joséphine Yrinesi, Marie-Thérèse Ekala, Julie Péneau, Béatrice Volney, Franck Berger, Christiane Bouchier, Stéphane Bertani, Lise Musset, Jean-Baptiste Meynard and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Efficacy of Artemether-Lumefantrine for UncomplicatedThe American journal of tropical medicine and hygiene · 2018
    Trial
  3. Article
  4. Article
  5. The structure ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Frontiers in pharmacology · 2022
    Article
  7. Article
  8. Article
  9. Dynamics ofPathogens and global health · 2019
    Article
  10. Role of K13 Mutations in Artemisinin-Based Combination Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  11. Article
  12. Fusion of field studies and the laboratory solves a puzzle in antimalarial resistance.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Eric LegrandInstitut Pasteur de la Guyane, Centre National de Référence sur la Chimiorésistance du Paludisme dans la région Antilles—Guyane, Cayenne, French Guiana. elegrand@pasteur-cayenne.fr
Joséphine Yrinesi
Marie-Thérèse Ekala
Julie Péneau
Béatrice Volney
Franck Berger
Christiane Bouchier
Stéphane Bertani
Lise Musset
Jean-Baptiste Meynard
Odile Mercereau-Puijalon
Institut Pasteur de la Guyane · GFInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analysis of the evolution of drug target genes under changing drug policy is needed to assist monitoring of Plasmodium falciparum drug resistance in the field. Here we genotype Pfcrt and Pfdmr1 of 700 isolates collected in French Guiana from 2000 (5 years after withdrawal of chloroquine) to 2008, i.e., the period when the artemether-lumefantrine combination was progressively introduced and mefloquine was abandoned. Gene sequencing showed fixation of the 7G8-type Pfcrt SMVNT resistance haplotype and near fixation of the NYCDY Pfdmr1 haplotype. Pfdmr1 gene copy number correlated with 50% inhibitory concentrations of mefloquine and halofantrine (r = 0.64 and 0.47, respectively, n = 547); its temporal changes paralleled changes in in vitro mefloquine susceptibility. However, the molecular parameters studied did not account for the regained in vitro susceptibility to chloroquine and showed a poor correlation with susceptibility to artemether, lumefantrine, or quinine. Identification of novel markers of resistance to these antimalarials is needed in this South American area.

Indexed as

AminoquinolinesAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsATP-Binding Cassette, Sub-Family C ProteinsChloroquineDrug CombinationsDrug ResistanceEthanolaminesEvolution, MolecularFluorenesFrench GuianaGene DosageHaplotypesHumansInhibitory Concentration 50AminoquinolinesAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsATP-Binding Cassette, Sub-Family C ProteinsChloroquineDrug CombinationsEthanolaminesFluoreneshalofantrineMdr1 protein, Plasmodium falciparumMefloquineMembrane Transport ProteinsPfCRT protein, Plasmodium falciparumPhenanthrenesProtozoan ProteinsQuinine

Identifiers

PMID22232280
PMCPMC3294927
OpenAlexW1971834198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.